NCT05510778

Brief Summary

Consumption of a high-fiber diet, often consisting of beans and vegetables, is recommended for improvements in overall health. Unfortunately, intake of the above-mentioned foods is often associated with a significant increase in intestinal gas production. In addition to gas, abdominal bloating, cramping, and associated symptoms can prove unacceptable-leading people to limit or abandon the consumption of bean-rich meals. In an attempt to reduce gas formation and the ensuing symptoms, various anti-gas products have been developed and are sold on the market. One such non-prescription product is Beano, a solution of the enzyme alpha-galactosidase. In addition to alpha-galactosidase, activated charcoal has also been used successfully in some, but not all, studies and may be a good option for certain individuals. CharcoCaps® is a branded form of activated charcoal that has been sold for several years.That said, no controlled studies have been conducted using CharcoCaps®. This study will investigate the effects of ingesting CharcoCaps® before and following the meal on the amount of gas produced, the number of flatus events, and associated symptoms of GI distress during the 6-hour post meal ingestion period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2021

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2021

Completed
8 months until next milestone

First Posted

Study publicly available on registry

August 22, 2022

Completed
Last Updated

August 22, 2022

Status Verified

August 1, 2022

Enrollment Period

3 months

First QC Date

December 8, 2021

Last Update Submit

August 19, 2022

Conditions

Keywords

CharcocapsIntestinal gasBreath Hydrogen

Outcome Measures

Primary Outcomes (33)

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    0 minutes before chili meal consumed (baseline)

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    30 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    60 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    90 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    120 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    150 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    180 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    210 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    240 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    270 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    300 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    330 minutes post meal consumption

  • Breath Hydrogen

    Hydrogen measured in exhale using H2 Check Analyzer

    360 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    baseline

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    30 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    60 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    90 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    120 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    150 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    180 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    210 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    240 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    270 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    300 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    330 minutes post meal consumption

  • Gastrointestinal Symptoms Questionnaire

    Questionnaire that subject self-report the severity of gastrointestinal symptoms using a scale of 0 (no symptoms) to 10 (severe symptoms) for Bloating, Flatulence, Abdominal Rumblings, Abdominal Pain/Cramping, Stomach Fullness, Nausea, and Overall physical discomfort

    360 minutes post meal consumption

  • Flatus events

    Self-reported number of flatus events each hour

    baseline

  • Flatus events

    Self-reported number of flatus events each hour

    60 minutes post meal consumption

  • Flatus events

    Self-reported number of flatus events each hour

    120 minutes post meal consumption

  • Flatus events

    Self-reported number of flatus events each hour

    180 minutes post meal consumption

  • Flatus events

    Self-reported number of flatus events each hour

    240 minutes post meal consumption

  • Flatus events

    Self-reported number of flatus events each hour

    300 minutes post meal consumption

  • Flatus events

    Self-reported number of flatus events each hour

    360 minutes post meal consumption

Secondary Outcomes (1)

  • Concluding Questionnaire

    60 minutes post meal consumption

Study Arms (2)

Charcocaps

EXPERIMENTAL

2 capsules 15 minutes before meal and 2 additional capsules 2 hours after meal

Dietary Supplement: Charcocaps

Placebo

PLACEBO COMPARATOR

2 capsules 15 minutes before meal and 2 additional capsules 2 hours after meal

Other: Placebo

Interventions

CharcocapsDIETARY_SUPPLEMENT

250 mg capsules containing Activated charcoal, Gelatin, Titanium Dioxide, and Carmine

Charcocaps
PlaceboOTHER

capsules containing \~250 mg cellulose

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-report of at least one of the following symptoms after eating meals rich in complex carbohydrates (such as beans):
  • Abdominal bloating/pain/cramps
  • Flatulence/gas
  • Willing to consume a meatless chili meal and steamed broccoli
  • No consumption of alcohol-containing beverages within 24 hours of testing
  • No consumption of caffeine-containing beverages within 24 hours of testing
  • No strenuous exercise within 24 hours of testing
  • Be able to fast overnight (\>10 hrs)

You may not qualify if:

  • Diagnosed GI condition
  • Diabetic
  • Pregnant/lactating
  • Self-reported active infection or illness of any kind
  • Tobacco product user
  • Hypersensitivity or allergy to any component of the supplement or chili (Activated charcoal, Gelatin, Titanium Dioxide, and Carmine, black beans, kidney beans, pinto beans, tomato puree, bell peppers, onion, sweet potato, chili powder, onion powder, garlic powder, salt, pepper, cumin, oregano, broccoli)
  • Taking any anti-gas, or anti-flatulence medication or dietary supplements, or if taking only non-prescribed supplements/mediations, not willing to cease use of them during study period
  • A regular consumer of bean meals (no more than once weekly)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Nutraceutical and Dietary Supplement Research

Memphis, Tennessee, 38152, United States

Location

MeSH Terms

Conditions

Anthrax

Interventions

Charcoal

Condition Hierarchy (Ancestors)

Bacillaceae InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfections

Intervention Hierarchy (Ancestors)

CarbonElementsInorganic Chemicals

Study Officials

  • Richard Bloomer, PhD

    University of Memphis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Charcocaps and placebo capsules are similar in appearance and provided to investigators pre-masked (A and B).
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: double-blind, placebo controlled, cross-over
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dean of the College of Health Sciences

Study Record Dates

First Submitted

December 8, 2021

First Posted

August 22, 2022

Study Start

September 30, 2021

Primary Completion

December 22, 2021

Study Completion

December 22, 2021

Last Updated

August 22, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations